Chronic hyperprolactinemia and changes in dopamine neurons

被引:23
|
作者
Mohankumar, PS
Mohankumar, SMJ
Kaleem, S
Quadri, SK
Voogt, JL
机构
[1] UNIV KANSAS,MED CTR,DEPT PHYSIOL,KANSAS CITY,KS 66160
[2] KANSAS STATE UNIV,DEPT ANAT & PHYSIOL,MANHATTAN,KS 66506
关键词
prolactin; catecholamines; aging; microdissection; HPLC-EC;
D O I
10.1016/S0361-9230(96)00369-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The tuberoinfundibular dopaminergic (TIDA) system is known to inhibit prolactin (PRL) secretion. In young animals this system responds to acute elevations in serum PRL by increasing its activity. However, this responsiveness is lost in aging rats with chronically high serum PRL levels. The purpose of this study was to induce hyperprolactinemia in rats for extended periods of time and examine its effects on dopaminergic systems in the brain. Hyperprolactinemia was induced by treatment with haloperidol, a dopamine receptor antagonist, and Palkovits' microdissection technique in combination with high-performance liquid chromatography was used to measure neurotransmitter concentrations in several areas of the brain. After 6 months of hyperprolactinemia, dopamine (DA) concentrations in the median eminence (ME) increased by 84% over the control group. Nine months of hyperprolactinemia produced a 50% increase in DA concentrations in the ME over the control group. However, DA response was lost if a 9-month long haloperidol-induced hyperprolactinemia was followed by a 1 1/2, month-long extremely high increase in serum PRL levels produced by implantation of MMQ cells under the kidney capsule. There was no change in the levels of DA, norepinephrine (NE), serotonin (5-HT), or their metabolites in the arcuate nucleus (AN), medial preoptic area (MPA), caudate putamen (CP), substantia nigra (SN), and zona incerta (ZI), except for a decrease in 5-hydroxyindoleacetic acid (5-HIAA) in the AN after B-months of hyperprolactinemia and an increase in DA concentrations in the AN after g-months of hyperprolactinemia. These results demonstrate that hyperprolactinemia specifically affects TIDA neurons and these effects vary, depending on the duration and intensity of hyperprolactinemia. The age-related decrease in hypothalamic dopamine function may be associated with increases in PRL secretion. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:435 / 441
页数:7
相关论文
共 50 条
  • [1] Chronic estradiol exposure induces oxidative stress in the hypothalamus to decrease hypothalamic dopamine and cause hyperprolactinemia
    MohanKumar, Sheba M. J.
    Kasturi, Badrinarayanan S.
    Shin, Andrew C.
    Balasubramanian, Priya
    Gilbreath, Ebony T.
    Subramanian, Madhan
    MohanKumar, Puliyur S.
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2011, 300 (03) : R693 - R699
  • [2] Role of noradrenaline in the development of dopamine-induced hyperprolactinemia
    Dilmukhametova, L. K.
    Pronina, T. S.
    Ziiazetdinova, G. Z.
    Kudrin, V. S.
    Ugrumov, M. V.
    NEUROCHEMICAL JOURNAL, 2009, 3 (04) : 288 - 296
  • [3] Role of noradrenaline in the development of dopamine-induced hyperprolactinemia
    L. K. Dilmukhametova
    T. S. Pronina
    G. Z. Ziiazetdinova
    V. S. Kudrin
    M. V. Ugrumov
    Neurochemical Journal, 2009, 3 : 288 - 296
  • [4] EFFECTS OF ACUTE AND CHRONIC COCAINE ON THE ACTIVITY OF TUBEROINFUNDIBULAR DOPAMINE NEURONS IN THE RAT
    BAUMANN, MH
    ROTHMAN, RB
    BRAIN RESEARCH, 1993, 608 (01) : 175 - 179
  • [5] Is chronic nipple piercing associated with hyperprolactinemia?
    Grace E. Ching Sun
    Kevin M. Pantalone
    Manjula Gupta
    Laurence Kennedy
    Christian Nasr
    Marigel Constantiner
    Amir H. Hamrahian
    Betul Hatipoglu
    Pituitary, 2013, 16 : 351 - 353
  • [6] Is chronic nipple piercing associated with hyperprolactinemia?
    Sun, Grace E. Ching
    Pantalone, Kevin M.
    Gupta, Manjula
    Kennedy, Laurence
    Nasr, Christian
    Constantiner, Marigel
    Hamrahian, Amir H.
    Hatipoglu, Betul
    PITUITARY, 2013, 16 (03) : 351 - 353
  • [7] EVIDENCE FOR A PATHOLOGICAL REDUCTION IN BRAIN DOPAMINE METABOLISM IN IDIOPATHIC HYPERPROLACTINEMIA
    PARADISI, R
    GROSSI, G
    PINTORE, A
    VENTUROLI, S
    PORCU, E
    CAPELLI, M
    FLAMIGNI, C
    ACTA ENDOCRINOLOGICA, 1991, 125 (03): : 246 - 252
  • [8] Circulating nitric oxide changes throughout the menstrual cycle in healthy women and women affected by pathological hyperprolactinemia on dopamine agonist therapy
    Giusti, M
    Fazzuoli, L
    Cavallero, D
    Valenti, S
    GYNECOLOGICAL ENDOCRINOLOGY, 2002, 16 (05) : 407 - 412
  • [9] Ischemic stroke risk in patients with dopamine agonist-treated hyperprolactinemia
    Akirov, Amit
    Rudman, Yaron
    Sharon, Yael
    Shimon, Ilan
    Kushnir, Shiri
    Diker-Cohen, Talia
    JOURNAL OF NEUROENDOCRINOLOGY, 2025,
  • [10] Metabolic syndrome associated with hyperprolactinemia: A new indication for dopamine agonist treatment?
    Bernabeu, Ignacio
    Casanueva, Felipe F.
    ENDOCRINE, 2013, 44 (02) : 273 - 274